Haleon, the global consumer health company behind leading brands such as Panadol, Sensodyne, Macleans, Otrivin and Voltaren, is deepening its presence in Nigeria as it rolls out its corporate identity across the country while expanding local manufacturing through a partnership with Fidson Healthcare.
The company disclosed that Panadol Extra 100s and Panadol Pain & Fever 100s are already being produced and supplied to the Nigerian market under the Haleon identity, marking a significant step in its strategy to strengthen local production and improve access to essential healthcare products.
The move comes nearly four years after Haleon formally separated from pharmaceutical giant GSK to become an independent consumer healthcare company focused exclusively on everyday health products.
Under the phased transition, consumers will begin seeing the Haleon corporate identity on packaging across its portfolio, starting with Sensodyne Rapid Action from mid-June and Andrews Liver Salts later this year. Other brands, including Otrivin,
This post was originally published on this site.
